231 related articles for article (PubMed ID: 26159701)
1. ▼Umeclidinium: another LAMA for COPD.
Drug Ther Bull; 2015 Jul; 53(7):81-4. PubMed ID: 26159701
[TBL] [Abstract][Full Text] [Related]
2. Umeclidinium for the treatment of chronic obstructive pulmonary disease.
Segreti A; Calzetta L; Rogliani P; Cazzola M
Expert Rev Respir Med; 2014 Dec; 8(6):665-71. PubMed ID: 25312239
[TBL] [Abstract][Full Text] [Related]
3. The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects.
Feldman GJ; Edin A
Ther Adv Respir Dis; 2013 Dec; 7(6):311-9. PubMed ID: 24004659
[TBL] [Abstract][Full Text] [Related]
4. Umeclidinium for treating COPD: an evaluation of pharmacologic properties, safety and clinical use.
Manickam R; Asija A; Aronow WS
Expert Opin Drug Saf; 2014 Nov; 13(11):1555-61. PubMed ID: 25294427
[TBL] [Abstract][Full Text] [Related]
5. An update on LAMA/LABA combinations for COPD.
Drug Ther Bull; 2017 Jan; 55(1):2-5. PubMed ID: 28057707
[TBL] [Abstract][Full Text] [Related]
6. Long-acting muscarinic antagonists.
Melani AS
Expert Rev Clin Pharmacol; 2015; 8(4):479-501. PubMed ID: 26109098
[TBL] [Abstract][Full Text] [Related]
7. Umeclidinium bromide and vilanterol in combination for the treatment of chronic obstructive pulmonary disease.
Kelly E
Expert Rev Clin Pharmacol; 2014 Jul; 7(4):403-13. PubMed ID: 24909949
[TBL] [Abstract][Full Text] [Related]
8. The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease.
Maltais F; Milot J
Ther Adv Respir Dis; 2012 Dec; 6(6):345-61. PubMed ID: 23075544
[TBL] [Abstract][Full Text] [Related]
9. Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.
Mastrodicasa MA; Droege CA; Mulhall AM; Ernst NE; Panos RJ; Zafar MA
Expert Opin Investig Drugs; 2017 Feb; 26(2):161-174. PubMed ID: 28004591
[TBL] [Abstract][Full Text] [Related]
10. Inhaled Umeclidinium in COPD Patients: A Review and Meta-Analysis.
Pleasants RA; Wang T; Gao J; Tang H; Donohue JF
Drugs; 2016 Mar; 76(3):343-61. PubMed ID: 26755180
[TBL] [Abstract][Full Text] [Related]
11. Aclidinium for COPD?
Drug Ther Bull; 2013 Apr; 51(4):45-8. PubMed ID: 23575603
[TBL] [Abstract][Full Text] [Related]
12. Umeclidinium/vilanterol fixed-dose combination for COPD.
Gras J
Drugs Today (Barc); 2014 Mar; 50(3):231-8. PubMed ID: 24696868
[TBL] [Abstract][Full Text] [Related]
13. ▾Glycopyrronium for COPD.
Drug Ther Bull; 2013 Jun; 51(6):66-8. PubMed ID: 23744364
[TBL] [Abstract][Full Text] [Related]
14. Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease.
Jones PW
Int J Chron Obstruct Pulmon Dis; 2015; 10():677-87. PubMed ID: 25848244
[TBL] [Abstract][Full Text] [Related]
15. Dose response of umeclidinium administered once or twice daily in patients with COPD: a pooled analysis of two randomized, double-blind, placebo-controlled studies.
Donohue JF; Kalberg C; Shah P; Beerahee M; Mehta R; Gunawan R; Church A
J Clin Pharmacol; 2014 Nov; 54(11):1214-20. PubMed ID: 24895108
[TBL] [Abstract][Full Text] [Related]
16. Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease.
Jones PW
Ther Adv Respir Dis; 2015 Jun; 9(3):84-96. PubMed ID: 25801643
[TBL] [Abstract][Full Text] [Related]
17. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
Joos GF
Expert Opin Investig Drugs; 2010 Feb; 19(2):257-64. PubMed ID: 20047505
[TBL] [Abstract][Full Text] [Related]
18. Safety of inhaled long-acting anti-muscarinic agents in COPD.
Hanania NA; Lareau SC; Yawn BP
Postgrad Med; 2017 Jun; 129(5):500-512. PubMed ID: 28395575
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic antagonists in early stage clinical development for the treatment of asthma.
Albertson TE; Chenoweth JA; Adams JY; Sutter ME
Expert Opin Investig Drugs; 2017 Jan; 26(1):35-49. PubMed ID: 27927039
[TBL] [Abstract][Full Text] [Related]
20. The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
Malerba M; Radaeli A; Santini G; Morjaria J; Mores N; Mondino C; Macis G; Montuschi P
Expert Opin Drug Discov; 2018 Jun; 13(6):563-577. PubMed ID: 29616842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
